Ono Pharmaceutical Announces Collaboration Agreement with MOLCURE
By, Admin1 min read
Share
Ono Pharmaceutical announced that it has entered into a drug discovery collaboration agreement with MOLCURE to discover and develop innovative antibody drugs for multiple targets utilizing MOLCURE
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
